Ruxolitinib Boosts Survival In Patients With Myelofibrosis
6/29/2013
STOCKHOLM - Continuous ruxolitinib therapy extends survival over that seen with best available therapy (BAT) in patients with myelofibrosis and also provides durable reductions in splenomegaly, according to results released at the 18th Congress of the European Hematology Association (EHA)...
Fish Oils Reduce Risk Of Breast Cancer
6/28/2013
Consuming fish oils can significantly lower a person's risk of developing breast cancer, according to a new study published in the BMJ. The researchers reviewed 21 different independent prospective cohort studies, they found that a high intake of fish and marine n-3 polyunsaturated fatty acids was associated with a 14 percent reduced risk of breast cancer...
University Of East Anglia Scientists Make Major Advances Important For Cancer Research
6/28/2013
Scientists at the University of East Anglia have made a major advancement in understanding tissue development that has important implications for cancer. Findings published today in the journal Cell Science show how the protein EB2 is a key regulator of tube-like structures inside cells and critical for normal tissue development and function...
Identification Of Important Genomic Variations Will Likely Impact Down Syndrome
6/28/2013
Down syndrome, more commonly known as "trisomy 21" is very often accompanied by pathologies found in the general population: Alzheimer's disease, leukemia, or cardiac deficiency...
Risk Of Stroke Effectively Reduced By Simple 2-Drug Combination
6/28/2013
Results of a Phase III clinical trial showed that a simple drug regimen of two anti-clotting drugs - clopidogrel and aspirin- lowered the risk of stroke by almost one-third, compared to the standard therapy of aspirin alone, when given to patients who had minor or transient stroke symptoms to prevent subsequent attacks...
Issue III Registry Defines Best Syncope Candidates For Cardiac Pacing
6/28/2013
Two important studies were released at the Late Breaking Clinical Trials session II at EHRA EUROPACE 2013. The PREFER AF study found that Oral anticoagulation is now used in over 85% of patients with atrial fibrillation (AF) eligible for therapy...
Aggressive Prostate Cancers In Black Men May Be Missed During 'Active Surveillance'
6/28/2013
A Johns Hopkins study of more than 1,800 men ages 52 to 62 suggests that African-Americans diagnosed with very-low-risk prostate cancers are much more likely than white men to actually have aggressive disease that goes unrecognized with current diagnostic approaches...
First Large-Scale Comparison Shows Human And Canine Lymphomas Share Molecular Similarities
6/28/2013
Humans and their pet dogs are close, so close that they both develop a type of cancer called diffuse large B-cell lymphoma. In humans it's the most common lymphoma subtype while in dogs, it's one of the most common cancers in veterinary oncology...
Care Of Limited-Stage Small-Cell Lung Cancer Patients Improved By PET-CT
6/28/2013
Each year, 13 percent of all newly diagnosed lung cancer patients are diagnosed with small-cell lung cancer (SCLC). Approximately 39 percent of patients with SCLC are diagnosed with limited-stage disease, meaning the cancer is only present in one lung, but may have spread to lymph nodes or tissue between the lungs...
More Research Needed On Treatment For Lung Cancer In Female 'Never Smokers'
6/28/2013
The incidence of lung cancer in women affects an estimated 516,000 women worldwide, of which 100,000 are in the United States and 70,000 in Europe. Until now, lung cancers occurring in women have been treated similarly to lung cancers in men. However, numerous studies have highlighted different characteristics of lung cancer in women...